Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: Clinical Outcome after Long-term Follow-up
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The optimal duration and interval of follow-up for cystic lesions of the pancreas (CLPs) is not well established. This study was performed to investigate the optimal duration and interval of follow-up for CLPs in clinical practice. Methods: Patients with CLPs without worrisome features or high-risk stigmata underwent followup with computed tomography at 6, 12, 18, and 24 months and then every 12 months thereafter. A retrospective analysis of prospectively collected data was performed. Results: A total of 227 patients with CLPs detected from 2000 to 2008 (mean initial diameter, 1.3±0.6 cm) underwent follow-up for a median of 120 months. Twenty-two patients (9.7%) underwent surgery after a median of 47.5 months. Malignancies developed in four patients (1.8%), one within 5 years and three within 10 years. One hundred and fourteen patients (50.2%) were followed up for more than 10 years. No malignancy developed after 10 years of follow-up. During surveillance, 37 patients (16.3%) experienced progression to surgical indication. In patients with CLPs less than 2 cm in diameter, development of surgical indications did not occur within 24 months of follow-up. Conclusions: CLPs should be continuously monitored after 5 years because of the persistent potential for malignant transformation of CLPs. An interval of 24 months for initial follow-up might be enough for CLPs with initial size of less than 2 cm in clinical practice.
Abstract
Background/Aims: The optimal duration and interval of follow-up for cystic lesions of the pancreas (CLPs) is not well established. This study was performed to investigate the optimal duration and interval of follow-up for CLPs in clinical practice. Methods: Patients with CLPs without worrisome features or high-risk stigmata underwent followup with computed tomography at 6, 12, 18, and 24 months and then every 12 months thereafter. A retrospective analysis of prospectively collected data was performed. Results: A total of 227 patients with CLPs detected from 2000 to 2008 (mean initial diameter, 1.3±0.6 cm) underwent follow-up for a median of 120 months. Twenty-two patients (9.7%) underwent surgery after a median of 47.5 months. Malignancies developed in four patients (1.8%), one within 5 years and three within 10 years. One hundred and fourteen patients (50.2%) were followed up for more than 10 years. No malignancy developed after 10 years of follow-up. During surveillance, 37 patients (16.3%) experienced progression to surgical indication. In patients with CLPs less than 2 cm in diameter, development of surgical indications did not occur within 24 months of follow-up. Conclusions: CLPs should be continuously monitored after 5 years because of the persistent potential for malignant transformation of CLPs. An interval of 24 months for initial follow-up might be enough for CLPs with initial size of less than 2 cm in clinical practice.
참고문헌 (26)
- Lee CJ, "Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size:is it safe to observe asymptomatic patients? A multi-institutional report", J Gastrointest Surg, 12, pp.234~242 (2008)
- Lee SH, "Outcomes of cystic lesions in the pancreas after extended follow-up", Dig Dis Sci, 52, pp.2653~2659 (2007)
- Broughton J, "Determining the natural history of pancreatic cystic neoplasms : a Manitoban cohort study", HPB(Oxford), 18, pp.383~388 (2016)
- Cadili A, "Survival in cystic neoplasms of the pancreas", Can J Gastroenterol, 23, pp.537~542 (2009)
- Crippa S, "Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing nonoperative management", Am J Gastroenterol, 112, pp.1153~1161 (2017)
- Han Y, "Progression of pancreatic branch duct intraductal papillary mucinous neoplasm associates with cyst size", Gastroenterology, 154, pp.576~584 (2018)
- Handrich SJ, "The natural history of the incidentally discovered small simple pancreatic cyst : long-term follow-up and clinical implications", AJR Am J Roentgenol, 184, pp.20~23 (2005)
- Kayal M, "Long-term surveillance and timeline of progression of presumed low-risk intraductal papillary mucinous neoplasms", AJR Am J Roentgenol, 209, pp.320~326 (2017)
- Khannoussi W, "The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas", Pancreatology, 12, pp.198~202 (2012)
- Kwong WT, "Low rates of malignancy and mortality in asymptomatic patients with suspected neoplastic pancreatic cysts beyond 5 years of surveillance", Clin Gastroenterol Hepatol, 14, pp.865~871 (2016)
- Marchegiani G, ""Trivial"cysts redefine the risk of cancer in presumed branch-duct intraductal papillary mucinous neoplasms of the pancreas : a potential target for follow-up discontinuation?", Am J Gastroenterol, 114, pp.1678~1684 (2019)
- Oyama H, "Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms", Gastroenterology, 158, pp.226~237 (2020)
- Pergolini I, "Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center", Gastroenterology, 153, pp.1284~1294 (2017)
- Yoen H, "Fate of small pancreatic cysts(<3 cm)after long-term follow-up : analysis of significant radiologic characteristics and proposal of follow-up strategies", Eur Radiol, 27, pp.2591~2599 (2017)
- Tanaka M, "Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas", Pancreatology, 17, pp.738~753 (2017)
- Elta GH, "ACG clinical guideline : diagnosis and management of pancreatic cysts", Am J Gastroenterol, 113, pp.464~479 (2018)
- European Study Group on Cystic Tumours of the Pancreas, "European evidence-based guidelines on pancreatic cystic neoplasms", Gut, 67, pp.789~804 (2018)
- Vege SS, "American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts", Gastroenterology, 148, pp.819~822 (2015)
- Das A, "Incidental cystic neoplasms of pancreas : what is the optimal interval of imaging surveillance?", Am J Gastroenterol, 103, pp.1657~1662 (2008)
- Kang MJ, "Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms", Clin Gastroenterol Hepatol, 9, pp.87~93 (2011)
- Kang JS, "Clinical validation of the 2017international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas", Ann Surg Treat Res, 97, pp.58~64 (2019)
- Srinivasan N, "Systematic review of the clinical utility and validity of the Sendai and Fukuoka Consensus Guidelines for the management of intraductal papillary mucinous neoplasms of the pancreas", HPB(Oxford), 20, pp.497~504 (2018)
- Yu S, "Validation of the 2012Fukuoka consensus guideline for intraductal papillary mucinous neoplasm of the pancreas from a single institution experience", Pancreas, 46, pp.936~942 (2017)
- Ko SW, "Prognosis and clinical characteristics of patients with pancreatic ductal adenocarcinoma diagnosed by endoscopic ultrasonography but indeterminate on computed tomography", Gut Liver, 16, pp.474~482 (2022)
- Kim GH, "Diagnostic concordance and preoperative risk factors for malignancy in pancreatic mucinous cystic neoplasms", Gut Liver, 16, pp.637~644 (2022)
- Ahn DW, "Long-term outcome of cystic lesions in the pancreas : a retrospective cohort study", Gut Liver, 6, pp.493~500 (2012)